These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9798262)

  • 1. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
    Rogóz Z; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z; Wróbel A; Krasicka-Domka M; Maj J
    Pol J Pharmacol; 1999; 51(5):399-404. PubMed ID: 10817540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
    Maj J; Rogóz Z
    J Neural Transm (Vienna); 1999; 106(2):197-211. PubMed ID: 10226939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of milnacipran, a new antidepressant, given acutely.
    Rogóz Z; Skuza G; Maj J
    Pol J Pharmacol; 1999; 51(4):317-22. PubMed ID: 10540963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some central effects of opipramol given repeatedly.
    Skuza G; Rogóz Z; Sowińska H
    Pol J Pharmacol Pharm; 1990; 42(5):425-31. PubMed ID: 2098752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation.
    Maj J; Rogóz Z; Skuza G; Margas W
    J Neural Transm (Vienna); 1998; 105(2-3):329-42. PubMed ID: 9660111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J; Rogóz Z; Sowińska H; Zalewski Z
    Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
    Nowakowska E; Kus K; Florek E; Czubak A; Jodynis-Liebert J
    Hum Exp Toxicol; 2006 Apr; 25(4):199-209. PubMed ID: 16696296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central effects of Ro 19-6327 given acutely and repeatedly.
    Skuza G; Rogóz Z
    Pol J Pharmacol Pharm; 1991; 43(6):437-47. PubMed ID: 1668212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
    Dhir A; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):921-5. PubMed ID: 17379375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of behavioural effects of venlafaxine and imipramine in rats.
    Nowakowska E; Kus K; Chodera A
    Arzneimittelforschung; 2003; 53(4):237-42. PubMed ID: 12785118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.
    Nowakowska E; Kus K
    Arzneimittelforschung; 2005; 55(3):153-9. PubMed ID: 15819387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacological profile of dexamisole.
    Przegaliński E; Bigajska K; Siwanowicz J
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.